Inventiva Aktie

2,49EUR -0,16EUR -5,86%
Inventiva für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2DLV9 / ISIN: FR0013233012

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 94 105 113 123 0
Umsatz pro Mitarbeiter in Mio. EUR 0,00 0,04 0,11 0,14 0,00

Bilanz (in Mio. EUR) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 132 115 106 48 0
Summe Anlagevermögen 6 6 10 21 0
Summe Aktiva 138 121 116 69 0

Bilanz (in Mio. EUR) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 28 33 71 102 0
Summe Eigenkapital 110 88 45 -32 0
Summe Passiva 138 121 116 69 0

Adresse

50, rue de Dijon, 21121 Daix
Telefon +33 (3) 80-44-75-00
Internet http://www.inventivapharma.com

Management

Alice Roudot-Ketelers
Chief Operating Officer
Annick Schwebig
Independent Director
David Nikodem
Vice President-US Operations
Eric Marie Albert Duranson
General Counsel
Frédéric Cren
Chief Executive Officer & Director
G. Andre Turenne
Independent Director
Heinz Christoph Mäusli
Independent Director
Jean Volatier
Chief Financial Officer
Kristina Meyer
EVP-Business Development & Alliance Management
Mark E. Pruzanski
Chairman
Martine Zimmermann
Independent Director
Michael P. Cooreman
Chief Medical Officer
Nathalie Harroy
Head-Human Resources
Pascaline Clerc
Executive VP-Strategy & Corporate Affairs
Pierre Broqua
Chief Scientific Officer & Deputy CEO
Srinivas Akkaraju
Independent Director
Xiao Qin Lu
Independent Director